arrow
J

Julien Lemaître

institut national de la santé et de la recherche médicale (inserm)
H指数:16
被引数:1,266

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Maintenance of intestinal CX3CR1+ macrophage homeostasis defines post-treatment control in SIV-infected macaques

维持肠道CX3CR1<sup>+</sup>巨噬细胞稳态决定了SIV感染恒河猴的治疗后控制

2026-02-240
OA
Whole-Body Dynamic PET Imaging of Half-Life Extended Variable Domains of Heavy Chain-Only Antibodies: Beyond Blood Pharmacokinetics

重链-only抗体半衰期延长可变域的全身动态PET成像:超越血药动力学

2026-01-010
PRE
Positron emission tomography-based comparison of methods for exposing macaques to respiratory pathogens

基于正电子发射断层扫描技术的灵长类动物暴露于呼吸道病原体的方法比较

2025-07-050
PRE
Rocuronium-specific antibodies drive perioperative anaphylaxis but can also function as reversal agents in preclinical models
2024-09-110
PRE
Immunogenicity and efficacy of VLA2001 vaccine against SARS-CoV-2 infection in male cynomolgus macaques
2024-04-031
OA
Early antiretroviral therapy favors post-treatment SIV control associated with the expansion of enhanced memory CD8+ T-cells

早期抗逆转录病毒治疗有利于与增强的记忆CD8 T细胞扩增相关的治疗后SIV控制

2024-01-1114
OAAI
SARS-CoV-2-related bat virus behavior in human-relevant models sheds light on the origin of COVID-19
2023-03-0610
PRE
Durable immunogenicity, adaptation to emerging variants, and low-dose efficacy of an AAV-based COVID-19 vaccine platform in macaques
2022-09-018
OAAI
Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates
2022-08-3020
OAAI
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models
2021-10-2033
OAAI
Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques
2021-09-0125
OAAI
Non-human primate models of human respiratory infections

人类呼吸道感染的非人灵长类动物模型

2021-07-0124
OAAI